{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:04:08Z","timestamp":1785441848751,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"DOI":"10.1007\/s11307-026-02128-2","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:47:09Z","timestamp":1785440829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of 1\u2078F-NaF PET\/CT"],"prefix":"10.1007","author":[{"given":"Mahdi","family":"Zirakchian Zadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2128_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349","journal-title":"CA Cancer J Clin"},{"key":"2128_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s42003-025-08384-2","volume":"8","author":"C S\u00e1nchez-de-Diego","year":"2025","unstructured":"S\u00e1nchez-de-Diego C, Yada RC, Sethakorn N et al (2025) Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response. Commun Biol 8:961","journal-title":"Commun Biol"},{"key":"2128_CR3","doi-asserted-by":"crossref","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer 18:44","DOI":"10.1186\/s12885-017-3922-0"},{"key":"2128_CR4","first-page":"14N","volume":"58","author":"KJ Donohoe","year":"2017","unstructured":"Donohoe KJ, Cohen EJ, Giammarile F et al (2017) Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts. J Nucl Med 58:14N-17N","journal-title":"J Nucl Med"},{"key":"2128_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40336-016-0196-5","volume":"4","author":"GJ Cook","year":"2016","unstructured":"Cook GJ, Azad G, Padhani AR (2016) Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology. Clin Transl Imaging 4:439\u2013447","journal-title":"Clin Transl Imaging"},{"key":"2128_CR6","volume-title":"Nuclear medicine and molecular imaging: the requisites","author":"JP O\u2019Malley","year":"2020","unstructured":"O\u2019Malley JP, Ziessman HA (2020) Nuclear medicine and molecular imaging: the requisites, 5th ed. Elsevier, Philadelphia","edition":"5th ed"},{"key":"2128_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1148\/rg.345130061","volume":"34","author":"S Bastawrous","year":"2014","unstructured":"Bastawrous S, Bhargava P, Behnia F, Djang DS, Haseley DR (2014) Newer PET applications with an old tracer: role of 1\u2078F-NaF skeletal PET\/CT in oncologic practice. Radiographics 34:1295\u20131316","journal-title":"Radiographics"},{"key":"2128_CR8","volume-title":"Essentials of nuclear medicine and molecular imaging","author":"FA Mettler","year":"2018","unstructured":"Mettler FA, Guiberteau MJ (2018) Essentials of nuclear medicine and molecular imaging, 7th ed. Elsevier, Philadelphia","edition":"7th ed"},{"key":"2128_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2967\/jnumed.112.114298","volume":"54","author":"KK Wong","year":"2013","unstructured":"Wong KK, Piert M (2013) Dynamic bone imaging with 99mTc-labeled diphosphonates and 1\u2078F-NaF: mechanisms and applications. J Nucl Med 54:590\u2013599","journal-title":"J Nucl Med"},{"key":"2128_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.semnuclmed.2016.07.003","volume":"46","author":"W Langsteger","year":"2016","unstructured":"Langsteger W, Rezaee A, Pirich C, Beheshti M (2016) 1\u2078F-NaF-PET\/CT and 99mTc-MDP bone scintigraphy in the detection of bone metastases in prostate cancer. Semin Nucl Med 46:491\u2013501","journal-title":"Semin Nucl Med"},{"key":"2128_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116957","volume":"179","author":"M Zirakchian Zadeh","year":"2024","unstructured":"Zirakchian Zadeh M (2024) The role of conventional and novel PET radiotracers in assessment of myeloma bone disease. Bone 179:116957","journal-title":"Bone"},{"key":"2128_CR12","first-page":"151","volume":"10","author":"MZ Zadeh","year":"2020","unstructured":"Zadeh MZ, Seraj SM, \u00d8stergaard B et al (2020) Prognostic significance of 1\u2078F-sodium fluoride in newly diagnosed multiple myeloma patients. Am J Nucl Med Mol Imaging 10:151\u2013160","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2128_CR13","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1007\/s00259-020-04768-0","volume":"47","author":"M Zirakchian Zadeh","year":"2020","unstructured":"Zirakchian Zadeh M, \u00d8stergaard B, Raynor WY et al (2020) Comparison of 1\u2078F-sodium fluoride uptake before and after therapy in multiple myeloma. Eur J Nucl Med Mol Imaging 47:2846\u20132855","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2128_CR14","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1007\/s12350-020-02446-0","volume":"28","author":"LS Arani","year":"2021","unstructured":"Arani LS, Zirakchian Zadeh M, Saboury B et al (2021) Assessment of atherosclerosis in multiple myeloma using 1\u2078F-sodium fluoride PET\/CT. J Nucl Cardiol 28:3044\u20133054","journal-title":"J Nucl Cardiol"},{"key":"2128_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s12149-020-01463-w","volume":"34","author":"SM Seraj","year":"2020","unstructured":"Seraj SM, Raynor WY, Revheim ME et al (2020) NaF-PET\/CT versus FDG-PET\/CT for detecting abdominal aortic calcification in rheumatoid arthritis. Ann Nucl Med 34:424\u2013431","journal-title":"Ann Nucl Med"},{"key":"2128_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2967\/jnmt.119.234336","volume":"48","author":"K Ahuja","year":"2020","unstructured":"Ahuja K, Sotoudeh H, Galgano SJ et al (2020) 1\u2078F-sodium fluoride PET: history, mechanism, and diagnostic performance. J Nucl Med Technol 48:9\u201316","journal-title":"J Nucl Med Technol"},{"key":"2128_CR17","doi-asserted-by":"publisher","first-page":"1320574","DOI":"10.3389\/fmed.2023.1320574","volume":"10","author":"E Ouvrard","year":"2024","unstructured":"Ouvrard E, Kaseb A, Poterszman N et al (2024) Nuclear medicine imaging for bone metastases in the era of personalized medicine. Front Med (Lausanne) 10:1320574","journal-title":"Front Med (Lausanne)"},{"key":"2128_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jmir.2023.12.008","volume":"55","author":"KB Singh","year":"2024","unstructured":"Singh KB, London KI, Wong VCK, Mansberg R (2024) Diagnostic accuracy of bone scan at different PSA levels in biochemical recurrence of prostate cancer. J Med Imaging Radiat Sci 55:91\u201396","journal-title":"J Med Imaging Radiat Sci"},{"key":"2128_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.juro.2010.03.033","volume":"184","author":"S Loeb","year":"2010","unstructured":"Loeb S, Makarov DV, Schaeffer EM, Humphreys EB, Walsh PC (2010) Prostate-specific antigen at initial diagnosis of bone metastasis after radical prostatectomy. J Urol 184:157\u2013161","journal-title":"J Urol"},{"key":"2128_CR20","doi-asserted-by":"publisher","unstructured":"Salerno I, Dunn N, White H, Miyazaki W, Jeziorski K, Silvestros D, Jha A, Laforest R, Akerele MI, Thomas MA, Thorek DLJ (2026) Quantitative comparison of SPECT and PET performance for clinical theranostic applications. J Nucl Med 67(3):423\u2013428. https:\/\/doi.org\/10.2967\/jnumed.125.270987","DOI":"10.2967\/jnumed.125.270987"},{"issue":"Suppl 1","key":"2128_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00259-011-1770-8","volume":"38","author":"P Ritt","year":"2011","unstructured":"Ritt P, Vija H, Hornegger J et al (2011) Absolute quantification in SPECT. Eur J Nucl Med Mol Imaging 38(Suppl 1):69\u201377","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2128_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2214\/ajr.142.4.773","volume":"142","author":"JJ Pollen","year":"1984","unstructured":"Pollen JJ, Witztum KF, Ashburn WL (1984) The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. AJR Am J Roentgenol 142:773\u2013776","journal-title":"AJR Am J Roentgenol"},{"key":"2128_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12149-024-01914-8","volume":"38","author":"X Zhang","year":"2024","unstructured":"Zhang X, Nakajima K, Mizokami A et al (2024) Flare phenomenon on 99mTc bone scintigraphy in metastatic castration-resistant prostate cancer. Ann Nucl Med 38:428\u2013440","journal-title":"Ann Nucl Med"},{"key":"2128_CR24","doi-asserted-by":"publisher","first-page":"108359","DOI":"10.1016\/j.bspc.2025.108359","volume":"111","author":"T Song","year":"2026","unstructured":"Song T et al (2026) Sci2Txt: automated report generation of low-resolution SPECT bone scintigrams. Biomed Signal Process Control 111:108359","journal-title":"Biomed Signal Process Control"},{"issue":"4","key":"2128_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/tomography7040050","volume":"7","author":"BR Koppula","year":"2021","unstructured":"Koppula BR, Morton KA, Al-Dulaimi R, Fine GC, Damme NM, Brown RKJ (2021) SPECT\/CT in the evaluation of suspected skeletal pathology. Tomography (Auckl) 7(4):581\u2013605. https:\/\/doi.org\/10.3390\/tomography7040050","journal-title":"Tomography (Auckl)"},{"key":"2128_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/onco4010002","volume":"4","author":"ZM Zirakchian","year":"2024","unstructured":"Zirakchian ZM (2024) Significance of PET\/CT imaging in myeloma assessment. Onco 4:15\u201336","journal-title":"Onco"},{"key":"2128_CR27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S1470-2045(22)00642-8","volume":"23","author":"F B\u00e9nard","year":"2022","unstructured":"B\u00e9nard F, Harsini S, Wilson D et al (2022) Intra-individual comparison of 1\u2078F-sodium fluoride PET\u2013CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Lancet Oncol 23:1499\u20131507","journal-title":"Lancet Oncol"},{"issue":"11","key":"2128_CR28","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.21037\/tcr-23-817","volume":"12","author":"Z Fan","year":"2023","unstructured":"Fan Z, Wang T, Zou L, Liu D (2023) Comparison of the diagnostic value of 1\u2078F-NaF PET\/CT and 99mTc-MDP SPECT for bone metastases: a systematic review and meta-analysis. Transl Cancer Res 12(11):3166\u20133178. https:\/\/doi.org\/10.21037\/tcr-23-817","journal-title":"Transl Cancer Res"},{"issue":"2","key":"2128_CR29","first-page":"287","volume":"47","author":"E Even-Sapir","year":"2006","unstructured":"Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I (2006) The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 1\u2078F-fluoride PET, and 1\u2078F-fluoride PET\/CT. J Nucl Med 47(2):287\u2013297","journal-title":"J Nucl Med"},{"key":"2128_CR30","unstructured":"Burton B, Danberry K, Hernandez A, McCleod C, Mendes C (2015) Comparative analysis of F18-NaF PET\/CT and Tc99m-MDP nuclear bone scans for detecting osseous metastases. J Nucl Med 56(supplement 3):2724"},{"key":"2128_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5975338","volume":"2022","author":"D Wang","year":"2022","unstructured":"Wang D, Yang Y, Zeng Z et al (2022) Comparison of bone metastases between 1\u2078F-NaF PET\/CT, 1\u2078F-NaF PET, and planar 99mTc-MDP bone scintigraphy in patients with newly diagnosed nasopharyngeal carcinoma. Contrast Media Mol Imaging 2022:5975338. https:\/\/doi.org\/10.1155\/2022\/5975338","journal-title":"Contrast Media Mol Imaging"},{"key":"2128_CR32","unstructured":"Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL (2018) SNMMI procedure standard for bone scintigraphy 4.0.. J Nucl Med Technol 46(4):398\u2013404"},{"issue":"2","key":"2128_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2967\/jnmt.109.070771","volume":"38","author":"MM Baqer","year":"2010","unstructured":"Baqer MM, Loutfi I (2010) Optimal imaging positions for 3-phase bone scanning of patients with bony pathology of the feet. J Nucl Med Technol 38(2):69\u201375. https:\/\/doi.org\/10.2967\/jnmt.109.070771","journal-title":"J Nucl Med Technol"},{"key":"2128_CR34","doi-asserted-by":"crossref","unstructured":"Fendler WP, Eiber M, Beheshti M et al (2023) PSMA PET\/CT: EANM\/SNMMI procedure guideline 2.0. Eur J Nucl Med Mol Imag 50:1466\u20131486","DOI":"10.1007\/s00259-022-06089-w"},{"key":"2128_CR35","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.3390\/cancers14153768","volume":"14","author":"S Rasul","year":"2022","unstructured":"Rasul S, Haug AR (2022) Clinical applications of PSMA PET in prostate cancer. Cancers 14:3768","journal-title":"Cancers"},{"key":"2128_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","volume":"22","author":"MK Bakht","year":"2025","unstructured":"Bakht MK, Beltran H (2025) Biological determinants of PSMA expression and heterogeneity in prostate cancer. Nat Rev Urol 22:26\u201345","journal-title":"Nat Rev Urol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-026-02128-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T19:47:11Z","timestamp":1785440831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-026-02128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":36,"alternative-id":["2128"],"URL":"https:\/\/doi.org\/10.1007\/s11307-026-02128-2","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author used a large language model (OpenAI) to improve clarity and language; no AI was used for data analysis or scientific content generation.","order":2,"name":"Ethics","label":"Generative AI in Scientific Writing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to Declare.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The figures were obtained from previously published articles with appropriate permissions or under open-access licensing. Of note, Figs.\u00a05 and 7, as well as the visual abstract, were created with the assistance of OpenAI based on the scientific facts already presented in this review article.","order":4,"name":"Ethics","label":"Figures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}